Home » Publications » Circulating biomarkers and resistance to endocrine therapy in metastatic breast cancers: correlative results from AZD9496 oral SERD Phase I trial

Circulating biomarkers and resistance to endocrine therapy in metastatic breast cancers: correlative results from AZD9496 oral SERD Phase I trial

Medicines Discovery Catapult

Related publications

Sign up for our newsletter

Receive our monthly newsletter, and occasional alerts when we have major announcements and collaboration opportunities.